The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125861941 12586194 1 I 2014 20160611 20160725 20160725 PER US-ASTRAZENECA-2016SE64835 ASTRAZENECA 62.00 YR M Y 82.60000 KG 20160725 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125861941 12586194 1 PS BYDUREON EXENATIDE 1 Subcutaneous U 22200 2 MG /wk
125861941 12586194 2 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral 20 MG, DAILY, GENERIC U 0
125861941 12586194 3 C OXYCODONE OXYCODONE 1 Oral 10.0MG EVERY 4 - 6 HOURS 0 10 MG
125861941 12586194 4 C OXYCODONE OXYCODONE 1 Oral EXTENDED, 10 MG EVERY 4 - 6 HOURS 0
125861941 12586194 5 C LYRICA PREGABALIN 1 Oral 0 50 MG TID
125861941 12586194 6 C LYRICA PREGABALIN 1 Oral 0 50 MG TID
125861941 12586194 7 C METHOCARBAMOL. METHOCARBAMOL 1 Oral 0 750 MG BID
125861941 12586194 8 C INVOKANMET 2 Oral 50/1000 MG TWICE A DAY 0
125861941 12586194 9 C REPAGLINIDE. REPAGLINIDE 1 Oral 2MG, 2-3 TIMES A DAY 0
125861941 12586194 10 C SIMVASTATIN. SIMVASTATIN 1 Oral 0 20 MG QD
125861941 12586194 11 C TERAZOSINE 2 Oral 0 10 MG QD
125861941 12586194 12 C BUPROPION. BUPROPION 1 Oral 0 150 MG QD
125861941 12586194 13 C BABY ASPIRIN ASPIRIN 1 Oral 0 81 MG QD
125861941 12586194 14 C CIALIS TADALAFIL 1 Oral 0 5 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125861941 12586194 1 Type 2 diabetes mellitus
125861941 12586194 2 Gastrooesophageal reflux disease
125861941 12586194 3 Pain
125861941 12586194 4 Pain
125861941 12586194 5 Neuralgia
125861941 12586194 6 Diabetes mellitus
125861941 12586194 7 Muscle relaxant therapy
125861941 12586194 8 Diabetes mellitus
125861941 12586194 9 Diabetes mellitus
125861941 12586194 10 Blood cholesterol abnormal
125861941 12586194 11 Bladder disorder
125861941 12586194 12 Stress
125861941 12586194 13 Cardiac disorder
125861941 12586194 14 Micturition disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125861941 12586194 Diabetes mellitus
125861941 12586194 Drug ineffective
125861941 12586194 Dyspepsia
125861941 12586194 Gastrooesophageal reflux disease
125861941 12586194 Nausea
125861941 12586194 Road traffic accident
125861941 12586194 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125861941 12586194 1 20160505 0
125861941 12586194 2 200912 0
125861941 12586194 3 2014 0
125861941 12586194 4 2014 0
125861941 12586194 5 2014 0
125861941 12586194 6 2014 0
125861941 12586194 7 2014 0
125861941 12586194 8 201605 0
125861941 12586194 9 2015 0
125861941 12586194 10 2008 0
125861941 12586194 11 2015 0
125861941 12586194 12 2010 0
125861941 12586194 13 2006 0
125861941 12586194 14 201505 0